Todos os posts

M-A de estudos randomizados | Colchicina e riscos de doença cardíaca coronariana.

4 Out, 2022 | 12:36h

Colchicine and coronary heart disease risks: A meta-analysis of randomized controlled clinical trials – Frontiers in Cardiovascular Medicine

Conteúdos relacionados:

M-A: Colchicine after percutaneous coronary intervention significantly reduces the risk of major adverse cardiovascular events in patients with symptomatic coronary artery disease.

Expert Analysis | Colchicine in acute coronary syndrome: when to commence?

M-A: Colchicine in patients with coronary artery disease – “colchicine reduces the risk of myocardial infarction and stroke, but has a higher rate of gastrointestinal upset with no influence on all‐cause mortality”.

Review: Colchicine and the heart.

M-A: Colchicine administration for percutaneous coronary intervention

M-A: Efficacy and safety of low-dose colchicine in patients with coronary disease

Meta-analysis: Colchicine reduces new cardiovascular events in patients with coronary artery disease

Expert analysis: Efficacy and safety of colchicine in patients with chronic stable coronary disease

#ESCCongress – [Abstract Only] Randomized trial: Colchicine in patients with chronic coronary disease

#ESCCongress – Randomized trial: Colchicine not beneficial for patients with acute coronary syndrome

#ESCCongress – Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

#AHA19 – [Abstract Only] Practice Changing? – Randomized Trial: Low-Dose Colchicine Improves Outcomes after Myocardial Infarction

Research: Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome

 

---

Diretriz | Tratamento cirúrgico de abdome agudo após cirurgia bariátrica no ambiente de emergência.

4 Out, 2022 | 12:35h

Operative management of acute abdomen after bariatric surgery in the emergency setting: the OBA guidelines – World Journal of Emergency Surgery

Conteúdo relacionado: AGA clinical practice update on evaluation and management of early complications after bariatric/metabolic surgery.

 

---

Seguimento de longo prazo de um estudo randomizado | Monoterapia com inibidor de P2Y12 vs. terapia antiplaquetária dupla (dual antiplatelet therapy – DAPT) após intervenção coronariana percutânea.

4 Out, 2022 | 12:34h

Long-term Effects of P2Y12 Inhibitor Monotherapy After Percutaneous Coronary Intervention: 3-Year Follow-up of the SMART-CHOICE Randomized Clinical Trial – JAMA Cardiology (link para o resumo – $ para o texto completo)

Estudo original: Randomized Trials: Shorter Duration of Dual Antiplatelet Therapy May be an Option for Patients Undergoing Percutaneous Coronary Intervention

 

Comentário no Twitter

In #RCT follow-up, P2Y12 inhibitor monotherapy after 3 months of DAPT found to be comparable with prolonged DAPT for preventing ischemic events. P2Y12 inhibitor monotherapy resulted in significantly lower rate of major bleeding for up to 3 yrs. https://t.co/pBv9X87lEg #Research pic.twitter.com/42Y28hPPT2

— JAMA Cardiology (@JAMACardio) September 30, 2022

 

---

Estudo randomizado | Intervenção comportamental entregue via mensagens de texto não reduziu as reinfecções por doenças sexualmente transmitidas em jovens.

4 Out, 2022 | 12:32h

Effectiveness of a behavioural intervention delivered by text messages (safetxt) on sexually transmitted reinfections in people aged 16-24 years: randomised controlled trial – The BMJ

Comunicado de imprensa: Texting young people about safe sex does not reduce STI reinfection – BMJ Newsroom

 

Comentário no Twitter

New research: Sending regular texts to young people who have recently had a sexually transmitted infection (#STI) to encourage #safesex does not reduce rates of chlamydia and gonorrhoea reinfection, finds a trial published by @bmj_latest today.https://t.co/OgQqPAsbS7 pic.twitter.com/0QTLqPuzDX

— BMJ (@bmj_company) September 29, 2022

 

---

Breve revisão | Estratégia de sedação ótima para pacientes críticos.

4 Out, 2022 | 12:31h

Seeking the Light in Intensive Care Unit Sedation: The Optimal Sedation Strategy for Critically Ill Patients – Frontiers in Medicine

 

---

Revisão | Lesão renal aguda em pacientes com doença hepática.

4 Out, 2022 | 12:29h

Acute Kidney Injury in Patients with Liver Disease – Clinical Journal of the American Society of Nephrology

 

Comentário no Twitter

AKI is commonly encountered in patients with decompensated cirrhosis, and it is associated with unfavorable outcomes. This article discusses tailoring management of AKI in patients with liver disease to the specific underlying etiology https://t.co/UVEeYBL8ff@VelezNephHepato pic.twitter.com/V5J8hBQyuw

— CJASN (@CJASN) September 27, 2022

 

---

Breve revisão | Lesão renal aguda relacionada a gestação: sabemos o que fazer?

4 Out, 2022 | 12:28h

Pregnancy-Related Acute Kidney Injury: Do We Know What to Do? – Nephron

 

---

Estudo randomizado | Eficácia analgésica da dexametasona intravenosa como um adjunto ao bloqueio paravertebral na cirurgia toracoscópica.

4 Out, 2022 | 12:27h

Analgesic Efficacy of Intravenous Dexamethasone as an Adjunct to Ultrasound-Guided Paravertebral Block with Bupivacaine in Video-Assisted Thoracoscopic Surgery – Journal of Pain Research

 

---

Estudo randomizado | Antibioticoprofilaxia vs. nenhuma profilaxia na cirurgia de câncer de mama.

4 Out, 2022 | 12:26h

Antibiotic prophylaxis in breast cancer surgery (PAUS trial): randomised clinical double-blind parallel-group multicentre superiority trial – British Journal of Surgery (link para o resumo – $ para o texto completo)

 

---

Revisão sistemática | Atividade física e exercícios na fibrose cística.

4 Out, 2022 | 12:25h

Physical activity and exercise training in cystic fibrosis – Cochrane Library

Resumo: Physical activity to improve exercise capacity in people with cystic fibrosis – Cochrane Library

 

Comentário no Twitter

🏃🚶‍♂️🏌️‍♂️🧘‍♂️ People with #cysticfibrosis probably benefit from physical activity interventions for six months: evidence from a recent #Cochrane review ➡️https://t.co/T3JyBm6bSd@CochraneLibrary @CochraneNursing #CochraneHongKong #SystematicReview #cuhknursing #exercise pic.twitter.com/evzTm7Xpo9

— Cochrane Nursing (@CochraneNursing) August 24, 2022

 

---